Publication Name	World Journal of Diabetes
Manuscript ID	99075
Country	Saudi Arabia

Received	2024-07-12 13:13
Peer-Review Started	2024-07-12 13:13
To Make the First Decision
Return for Revision	2024-08-26 03:21
Revised	2024-08-30 10:54
Second Decision	2024-09-05 02:40
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2024-09-05 08:13
Articles in Press	2024-09-05 08:13
Publication Fee Transferred
Edit the Manuscript by Language Editor	2024-09-06 11:20
Typeset the Manuscript	2024-09-30 04:44
Publish the Manuscript Online	2024-10-16 10:38

ISSN	1948-9358 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Endocrinology & Metabolism
Manuscript Type	Editorial
Article Title	Glucagon-like peptide-1 agonists: Role of the gut in hypoglycemia unawareness, and the rationale in type 1 diabetes
Manuscript Source	Invited Manuscript
All Author List	Hyder O Mirghani
Funding Agency and Grant Number
Corresponding Author	Hyder O Mirghani, MD, Professor, Internal Medicine, University of Tabuk, Prince Fahd Bin Sultan, Tabuk 51941, Tabuk, Saudi Arabia. s.hyder63@hotmail.com
Key Words	Glucagon-like peptide-1 receptor agonists; Glucagon response; Hypoglycemia unawareness; Gut; Type 1 diabetes
Core Tip	Poor glycemic control, nonadherence to insulin, vascular complication, and obesity remain major challenges in type 1 diabetes management. Glucagon-like peptide-1 receptor (GLP-1) agonists were shown to address the above without significant hypoglycemia. The rationale for GLP-1 use was based on the shared pathophysiology of type 1 and type 2 diabetes. The recent evidence of the gut involvement in GLP-1 agonists induced hypoglycemia unawareness and glucagon dysregulation is of great concern and the emerging role of GLP-1 agonists in the gut microbiota dysregulation and diversity could change diabetes management including type 1 diabetes. The use of GLP-1 agonists is better individualized.
Publish Date	2024-10-16 10:38
Citation	<p>Mirghani HO. Glucagon-like peptide-1 agonists: Role of the gut in hypoglycemia unawareness, and the rationale in type 1 diabetes. <i>World J Diabetes</i> 2024; 15(11): 2167-2172</p>
URL	https://www.wjgnet.com/1948-9358/full/v15/i11/2167.htm
DOI	https://dx.doi.org/10.4239/wjd.v15.i11.2167

Full Article (PDF)	WJD-15-2167-with-cover.pdf
Manuscript File	99075_Auto_Edited_031300.docx
Answering Reviewers	99075-answering-reviewers.pdf
Audio Core Tip	99075-audio.m4a
Conflict-of-Interest Disclosure Form	99075-conflict-of-interest-statement.pdf
Copyright License Agreement	99075-copyright-assignment.pdf
Non-Native Speakers of English Editing Certificate	99075-non-native-speakers.pdf
Peer-review Report	99075-peer-reviews.pdf
Scientific Misconduct Check	99075-scientific-misconduct-check.png
Scientific Editor Work List	99075-scientific-editor-work-list.pdf
CrossCheck Report	99075-crosscheck-report.pdf